证券代码：603829 证券简称：洛凯股份 公告编号：2026-006 江苏洛凯机电股份有限公司 关于第一大股东及其一致行动人减持股份结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： ● 大股东的基本情况 本次减持计划实施前，常州市洛辉投资有限公司（以下简称"洛辉投资"）持有江苏洛凯机电股份有限公 司（以下简称"洛凯股份"或"公司"）35,900,000股，占公司当前总股本的19.27%；常州市洛腾投资有限 公司（以下简称"洛腾投资"）持有公司32,300,000股，占公司当前总股本的17.34%；常州市洛盛投资合 伙企业（有限合伙）（以下简称"洛盛投资"）持有公司19,400,000股，占公司当前总股本的10.42%。洛 辉投资、洛腾投资、洛盛投资为一致行动人，合计持有公司股份87,600,000股，占公司总股本的 47.03%，所持股份均为IPO前取得。 ● 减持计划的实施结果情况 公司于2025年12月12日披露了洛辉投资、洛腾投资、洛盛投资本次减持计划，详见《关于第一大股东及 其一致行动人 ...

Meeting Overview - The first extraordinary general meeting of shareholders was held on February 9, 2026, at Shandong Yinglang Environmental Technology Co., Ltd. in Zibo City, Shandong Province [2] - The total number of shares entitled to vote at the meeting was 192,630,575, after excluding shares held in the company's repurchase account [2] Voting and Resolutions - The meeting was chaired by Ms. Jin Zhe, a director elected by the majority of the board, and utilized a combination of on-site and online voting methods [3] - A resolution regarding the change of certain fundraising projects and the adjustment of related asset uses was passed by a majority vote [6] - The voting process was compliant with the Company Law and the company's articles of association, ensuring the legality and validity of the resolutions [7] Attendance - Five current directors attended the meeting, while four were present, with the chairman unable to attend due to other commitments [4] - The company secretary and several executives were also present at the meeting [5] Legal Verification - The meeting was witnessed by Gao Peng (Shanghai) Law Firm, with lawyers confirming that the meeting's procedures and voting results were in accordance with legal requirements [7]

证券代码：603936 证券简称：博敏电子 公告编号：2026-016 重要内容提示： ● 担保对象及基本情况 （一）担保的基本情况 为满足日常经营及业务发展资金需求，江苏博敏与远东国际融资租赁有限公司以售后回租方式开展融资 租赁业务，融资额度为人民币16,500万元，期限为三年，博敏电子股份有限公司（以下简称"公司"）为 江苏博敏上述融资租赁提供不可撤销的全额连带责任保证担保，担保金额为16,500万元，并于2026年2 月9日与远东国际融资租赁有限公司签署了《保证合同》（合同编号：IFELC26DSENXHK5-U-01）。前 述担保不存在反担保情况。 （二）内部决策程序 公司分别于2025年4月24日、2025年5月23日召开第五届董事会第十九次会议、2024年年度股东大会审议 通过《关于公司2025年度对外担保额度预计的议案》，为保证公司及子公司向业务合作方申请授信或其 他经营业务的顺利开展，同意公司2025年度为子公司及子公司之间就上述综合授信额度内的融资提供合 计不超过22.50亿元新增的担保额度（其中为下属资产负债率70%以上的子公司提供新增担保不超过人 民币18.50亿元，为下属资产负债率70 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688466 证券简称：金科环境 公告编号：2026-003 金科环境股份有限公司 关于《锡东工业污水处理项目特许经营协议》终止 的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重点内容提示： ● 金科环境股份有限公司（以下简称"公司"）实施的锡东工业污水处理项目因公司向园区排污企业收取 的污水处理费未能保证项目连续三个月正常运转和投资收益要求，触发各方于2023年签署的《锡东工业 污水处理项目特许经营协议》（以下简称"《特许经营协议》"）中项目回购约定情形。相关方于2025年 12月签订《锡东工业污水处理项目特许经营终止协议》（以下简称"《终止协议》"），特许经营权终止 日为2025年3月31日。近日，公司控股子公司无锡市锡山荷泰污水处理有限公司（以下简称"项目公 司"或"锡山荷泰"）与锡山经济技术开发区管理委员会（以下简称"锡山经开区管委会"）指定主体无锡 云隆园区建设发展有限公司（以下简称"无锡云隆"）签订《锡东工业污水处理厂项目回购协议》（以下 ...

Core Viewpoint - The company, ZhenDe Medical, has decided to cancel repurchased shares and reduce its registered capital, impacting its total share capital and registered capital amounts. Group 1: Share Repurchase and Capital Reduction - The company will cancel a total of 1,959,310 shares, which includes 129,442 shares already repurchased and 1,829,868 shares from the second phase of the employee stock ownership plan that have not been unlocked. This change will alter the total share capital from 265,835,535 shares to 263,876,225 shares and reduce the registered capital from 265,835,535 yuan to 263,876,225 yuan [1][2]. Group 2: Notification to Creditors - Creditors are notified that they have 30 days from receiving the notice, or 45 days from the announcement date if no notice is received, to claim their debts or request guarantees. Failure to act within this timeframe will not affect the validity of their claims, and the company will continue to fulfill its obligations as per the original debt agreements [2]. Group 3: Debt Claim Submission Requirements - Creditors must provide original and copies of documents proving the existence of the debt relationship when submitting claims. Legal entities must also present their business license and identification of their legal representative, while individuals must provide valid identification [3]. Group 4: Debt Claim Submission Methods - Claims can be submitted in person, by mail, or via email. The submission period starts from February 10, 2026, and lasts for 45 days. Contact details for submissions include a physical address, phone number, and email [4][5].

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605069 证券简称：正和生态 公告编号：2026-005 北京正和恒基滨水生态环境治理股份有限公司 首次公开发行部分限售股上市流通公告 经中国证券监督管理委员会证监许可[2021]2490号文《关于核准北京正和恒基滨水生态环境治理股份有 限公司首次公开发行股票的批复》核准，北京正和恒基滨水生态环境治理股份有限公司（以下简称"本 公司"或"正和生态"）公开发行人民币普通股股票4,071.1111万股，并于2021年8月16日在上海证券交易 所挂牌上市。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 本次上市流通的限售股为公司首次公开发行股票形成的部分限售股，共计127,536,500股，涉及股东共计 3名，限售期为自公司股票上市之日起36个月，已于2024年8月15日届满。 重要内容提示： ● 本次股票上市类型为首发股份；股票认购方式为网下，上市股数为127,536,500股。 本次股票上市流通总数为127,536,500股。 ● 本次股票上市流通日期为202 ...

证券代码：600956 证券简称：新天绿能 公告编号：2026-002 新天绿色能源股份有限公司 关于董事会秘书离任 截至本公告日，班泽锋先生直接持有公司H股股票5万股，及依据公司2023年A股限制性股票激励计划已 授予但尚未解除限售的A股限制性股票20万股。辞职后，班泽锋先生将严格遵守《上市公司董事和高级 管理人员所持本公司股份及其变动管理规则》《上海证券交易所上市公司自律监管指引第15号一一股东 及董事、高级管理人员减持股份》及其他有关股份买卖的限制性规定，其所持有的A股限制性股票将依 照《上市公司股权激励管理办法》《新天绿色能源股份有限公司2023年A股限制性股票激励计划》等相 关规定，后续尽快办理回购注销手续。回购手续完成前，班泽锋先生将继续遵守作为激励对象所作出的 承诺。 二、离任对公司的影响 根据《公司法》《上海证券交易所股票上市规则》等有关规定，班泽锋先生的辞职报告自送达董事会之 日起生效，其辞职后将不再继续在公司担任其他职务。班泽锋先生所负责的工作已按照公司相关规定妥 善交接，除作为公司2023年A股限制股票激励对象所作出的承诺外，不存在其他应当履行而未履行的承 诺，其离任不会对公司的正常经营 ...

Core Viewpoint - The company held its first extraordinary general meeting of shareholders in 2026, where all proposed resolutions were approved without any objections [2][4]. Group 1: Meeting Details - The extraordinary general meeting was held on February 9, 2026, at the company's conference room located in Beijing [2]. - The meeting was convened by the board of directors and chaired by Chairman Wang Wei, utilizing a combination of on-site and online voting methods [2][3]. Group 2: Attendance - All nine current directors attended the meeting, along with the company’s vice president and board secretary, Yin Shi, and other senior management and witnessing lawyers [3]. Group 3: Resolutions Reviewed - A total of 23 resolutions were presented, all of which were approved, including: - Issuing shares to purchase assets and raising matching funds, which complies with relevant laws and regulations [4][8]. - Specific plans regarding the issuance of shares for asset purchases, including transaction prices, payment methods, and types of shares [5][6]. - Approval of the asset purchase agreement and related documents, including a profit compensation agreement [8][10]. Group 4: Voting and Legal Compliance - The resolutions were categorized as special resolutions, requiring more than two-thirds approval from the shares represented at the meeting [10]. - The company’s controlling shareholder, China Development Investment Group, which holds 44.57% of the total shares, abstained from voting on related resolutions [10]. - The meeting was witnessed by Beijing Jindu Law Firm, which confirmed that the meeting complied with relevant laws and regulations [10].

Group 1 - The core point of the announcement is the change in the shareholding structure of the controlling shareholder, Guangzhou Light Industry Trade Group Co., Ltd. (Light Industry Group) [1] - Before the change, Guangzhou Municipal Government held 90.03% of Light Industry Group, while Guangdong Provincial Department of Finance held 9.97%. After the change, Guangzhou Municipal Government holds 57.03%, Guangzhou Industrial Investment Holding Group Co., Ltd. (Guangzhou Investment) holds 33%, and Guangdong Provincial Department of Finance retains 9.97% [1] - The change in the shareholding structure does not affect the controlling shareholder or the actual controller of the company, which remains Light Industry Group and Guangzhou Municipal Government, respectively [2] Group 2 - The change in the shareholding structure does not impact Guangzhou Investment's direct shareholding in the company, which remains at 89,256,197 shares, accounting for 4.86% of the total share capital [2] - The company emphasizes that the change will not have a significant impact on its normal production and operational activities [2]

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688098 证券简称：申联生物 公告编号：2026-004 申联生物医药(上海)股份有限公司 关于持股5%以上股东权益变动触及1%刻度及减持计划完成暨减持股份结果公告 信息披露义务人UNITED BIOMEDICAL,INC.保证向本公司提供的信息真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏，并对其真实性、准确性和完整性依法承担法律责任。本公司董事会及全体 董事保证公告内容与信息披露义务人提供的信息一致。 重要内容提示： ● 股东持股的基本情况 本次减持计划实施前，美国联合生物医药公司（UNITED BIOMEDICAL,INC.以下简称"UBI"）持有申 联生物医药（上海）股份有限公司（以下简称"公司"或"申联生物"）43,199,898股股份，占公司总股本 的10.52%。上述股份来源为公司首次公开发行股票并上市前取得，且已于2020年10月28日后上市流 通。 ● 减持计划的实施结果情况 本次权益变动为UBI履行此前披露的减持股份计划所致，不触及要约收购。本次权益变动不会导致公司 控股股东、实际控制人发生变化，不会对公司治理结构及未 ...